Exploring Ketamine Treatment for Alcohol Use Disorder

Understanding Alcohol Use Disorder

Alcohol use disorder (AUD) is recognized as a chronic, relapsing condition characterized by persistent alcohol consumption despite adverse consequences. Currently, effective treatment options for AUD are limited, prompting researchers to investigate alternative therapies.

Ketamine as a Potential Treatment

Recent studies have explored the therapeutic potential of ketamine, a Schedule III drug, in addressing chronic alcohol consumption. Research indicates that ketamine may positively influence neural plasticity within the Nucleus Accumbens (NAc), a brain region linked to reward and drug-seeking behaviors. Notably, acute, low doses of ketamine have been shown to decrease alcohol intake in both chronically drinking rats and humans.

Study Overview

A study published in eNeuro by researchers at Florida State University examined the impact of ketamine on alcohol consumption in male and female Sprague Dawley rats. In total, 52 rats (25 males and 25 females) underwent training to utilize a two nose-poke hole system to receive a 45mg sugar pellet via an automated food hopper. Following a training phase, the rats participated in a 10-week, two-bottle choice program.

Experimental Design

During the first three weeks of the study, rats in the intervention group had access to a 20% alcohol solution and water three times a week, while alcohol-deprivation days consisted of two bottles of water. Researchers recorded fluid consumption and weight after each session to calculate daily alcohol intake (g/kg). The rats were subsequently categorized into high and low alcohol intake groups.

Following this initial phase, the water bottles were replaced with the self-administration of ketamine for the intervention group or saline for the non-intervention group during alcohol-deprivation days, spanning weeks four to seven. An intravenous catheter allowed for the administration of ketamine through a similar nose-poke method, with each poke resulting in a 50µL infusion of the drug.

Assessment of Ketamine Cravings

The rats then underwent a 21-day forced abstinence from ketamine while continuing to receive alcohol. Researchers evaluated ketamine cravings on days one, seven, and 21 by documenting the number of nose-pokes during this period.

Key Findings

The study revealed that female rats consumed higher alcohol doses compared to males and exhibited greater rates of ketamine self-administration. Interestingly, male rats with high alcohol intake demonstrated more significant reductions in ketamine self-administration than their low-intake counterparts for both alcohol and water.

During the 21-day abstinence phase, female rats displayed a higher number of nose-pokes for ketamine. In contrast, male rats showed increased nose-pokes in the ketamine self-administration group compared to the saline group on withdrawal days seven and 21, but not on day one. Additionally, male rats that consumed water instead of alcohol showed more nose-pokes than both low and high intake groups consuming alcohol, suggesting a potential link between alcohol intake and reduced ketamine cravings. This association was also noted in both low and high alcohol intake female rats.

Conclusion and Future Research

While further research, particularly involving human subjects, is necessary, the findings from this study suggest that low doses of ketamine could be beneficial in reducing alcohol intake, particularly for individuals consuming large quantities or those affected by AUD.

Written by P. Sukumar

References:

  • Strong, C.E., et al. (2019). eNeuro. Sex and individual differences in alcohol intake are associated with differences in ketamine self-administration behaviors and nucleus accumbens dendritic spine density.
  • Wellock, B. (2019). EurekAlert!. FSU research: Ketamine could help men suffering from alcohol use disorder.

Image by Tibor Janosi Mozes from Pixabay